Catalyst Wire Dossier Catalyst Wire Dossier

PRO-229 Ophthalmic Solution

· Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-229 Ophthalmic Solution, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF [Phase 1]

See pricing